Lentinan is a polysaccharide isolated from the fruit bodyofshiitake mushroom (Lentinula edodes).
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Molar mass | ~ 500,000 Da |
![]() ![]() |
Lentinan is a β-1,3 beta-glucan with β-1,6 branching. It has a molecular weight of 500,000 Da and specific rotation of +14-22° (NaOH).
Anin vitro experiment showed lentinan stimulated production of white blood cells in the human cell line U937.[1] Lentinan is thought to be inactive in humans when given orally and is therefore administered intravenously. The authors of an in vivo study of lentinan suggested that the compound may be active when administered orally in mice.[2]
Lentinan has been the subject of a limited number of clinical studies in cancer patients in Japan;[3][4][5][6][7][8][9][10] however, evidence of efficacy is lacking.[11][12]
Lentinan has been reported to cause shiitake mushroom dermatitis.[13]